A Research Study to Look at Long-term Treatment With a Medicine Called NNC6019-0001 for People Who Have Heart Failure Due to Transthyretin Amyloidosis

NCT06260709 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Interventions

DRUG: NNC6019-0001

Sponsor

Novo Nordisk A/S